Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych CASC / OSCEPsychopharmacology — monoamine oxidase inhibitors

Psych CASC / OSCE · Psychopharmacology — monoamine oxidase inhibitors

Explaining MAOI diet, washouts and patch options (CASC)

CASC-style communication station: shared decision on classic MAOI versus selegiline patch, practical tyramine teaching, washouts, and absolute drug bans without terror or false reassurance.

communication2 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 45-year-old professional with treatment-resistant depression and atypical features is offered phenelzine. She is frightened by 'cheese crisis' stories online, asks whether the selegiline patch is safer, and wonders if she can keep using tramadol for migraines and cold-and-flu tablets in winter.

Station instructions (candidate)

You have 7 minutes. Explain why an MAOI is being considered after multiple failed antidepressants, what the tyramine diet means in practical language, which medicines are absolute no-list items (including tramadol and many cold remedies), and how the selegiline patch differs on diet rules at 6 mg/24 h versus higher doses. Balance hope from TRD/atypical-depression evidence with honest safety requirements. Do not guarantee cure. Do not dismiss fear. Offer written materials and follow-up.[1][2][3][6]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this CASC / OSCE. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Van den Eynde V, Abdelmoemin WR, Abraham MM, et al. The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr, 2023.PMID 35837681
  2. [2]Van den Eynde V, Gillman PK, Blackwell BB The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles Psychopharmacol Bull, 2022.PMID 35721816
  3. [3]Bodkin JA, Amsterdam JD Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients Am J Psychiatry, 2002.PMID 12411221
  4. [4]Amsterdam JD A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder J Clin Psychiatry, 2003.PMID 12633131
  5. [5]Gillman PK Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity Br J Anaesth, 2005.PMID 16051647
  6. [6]Liebowitz MR, Quitkin FM, Stewart JW, et al. Antidepressant specificity in atypical depression Arch Gen Psychiatry, 1988.PMID 3276282
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousExplaining lithium versus valproate and pregnancy-safe planning (CASC)Psychopharmacology — mood stabilisersNextExplaining psychotropic choices in CKD and cirrhosis (CASC)Psychopharmacology — renal and hepatic disease